Kunkel Lori Anne 4
4 · Nurix Therapeutics, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Award
Director Stock Option (right to buy)
2024-05-20+25,000→ 25,000 totalExercise: $16.19Exp: 2034-05-19→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 20, 2025, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.